Loss of PBRM1 and BAP1 expression is less common in non–clear cell renal cell carcinoma than in clear cell renal cell carcinoma-Reference-Cited by-同舟云学术

Loss of PBRM1 and BAP1 expression is less common in non–clear cell renal cell carcinoma than in clear cell renal cell carcinoma

Published:2015-01 Issue:1 Volume:33 Page:23.e9-23.e14
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Ho Thai H.,Kapur Payal,Joseph Richard W.,Serie Daniel J.,Eckel-Passow Jeanette E.,Parasramka Mansi,Cheville John C.,Wu Kevin J.,Frenkel Eugene,Rakheja Dinesh,Stefanius Karoliina,Brugarolas James,Parker Alexander S.

Funder

National Institutes of Health

Cancer Prevention and Research Institute of Texas

Mayo Clinic

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference22 articles.

1. 2009 Update on the classification of renal epithelial tumors in adults;Lopez-Beltran;Int J Urol,2009

2. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma;Varela;Nature,2011

3. Comprehensive molecular characterization of clear cell renal cell carcinoma;Cancer Genome Atlas Research Network;Nature,2013

4. BAP1 loss defines a new class of renal cell carcinoma;Pena-Llopis;Nat Genet,2012

5. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes;Dalgliesh;Nature,2010

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An atypical presentation of renal mass associated with BAP-1 tumor predisposition syndrome: Case report and review of literature;Urology Case Reports;2024-05

2. Kidney cancer: Links between hereditary syndromes and sporadic tumorigenesis;Seminars in Diagnostic Pathology;2023-11

3. Signatures of Co-Deregulated Genes and Their Transcriptional Regulators in Kidney Cancers;International Journal of Molecular Sciences;2023-03-31

4. The expanding role of BAP1 in clear cell renal cell carcinoma;Human Pathology;2023-03

5. Molekulares Tumorboard – Nierenzellkarzinom;Die Urologie;2023